{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:42:43Z","timestamp":1772804563745,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.pathol.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T11:13:08Z","timestamp":1561461188000},"page":"507-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Heavy\/light chain assay in the monitoring of multiple myeloma"],"prefix":"10.1016","volume":"51","author":[{"given":"Huong Yew","family":"Ting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavai","family":"Sthaneshwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping Chong","family":"Bee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemalatha","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merrell","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.04.002_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx096","article-title":"Clinical practice guidelines for diagnosis, treatment and follow-up incidence and epidemiology","volume":"28","author":"Moreau","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2019.04.002_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A\u00a0long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.04.002_bib3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pathol.2019.04.002_bib4","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3","volume":"117","author":"Dimopoulos","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.04.002_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.6004\/jnccn.2013.0004","article-title":"Multiple myeloma, version 1.2013","volume":"11","author":"Anderson","year":"2013","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.pathol.2019.04.002_bib6","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1373\/clinchem.2009.124461","article-title":"Quantitation of serum monoclonal proteins: relationship between agarose gel electrophoresis and immunonephelometry","volume":"55","author":"Murray","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2019.04.002_bib7","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies","volume":"55","author":"Katzmann","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2019.04.002_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/leu.2013.293","article-title":"International Myeloma Working Group recommendations for global myeloma care","volume":"28","author":"Ludwig","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.04.002_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000456329102800310","article-title":"Overestimation of monoclonal immunoglobulin by immunochemical methods","volume":"28","author":"Riches","year":"1991","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.pathol.2019.04.002_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.04.002_bib11","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2009.123828","article-title":"Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin \u03ba\/\u03bb ratios","volume":"55","author":"Bradwell","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2019.04.002_bib12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2019.04.002_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.17219\/acem\/37036","article-title":"Immunoglobulin heavy chain\/light chain pairs (Hlc, HevyliteTM) assays for diagnosing and monitoring monoclonal gammopathies","volume":"23","author":"Kraj","year":"2014","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.pathol.2019.04.002_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3325\/cmj.2015.56.263","article-title":"Immunoglobulin heavy\/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients","volume":"56","author":"Batini\u0107","year":"2015","journal-title":"Croat Med J"},{"key":"10.1016\/j.pathol.2019.04.002_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ajh.21913","article-title":"Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management","volume":"86","author":"Rajkumar","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.04.002_bib16","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1158\/1078-0432.CCR-15-2899","article-title":"IgM\u03ba and IgM\u03bb measurements for the assessment of patients with Waldenstr\u00f6m's macroglobulinaemia","volume":"22","author":"Boyle","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.04.002_bib17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1373\/clinchem.2014.231985","article-title":"Monitoring IgA multiple myeloma: immunoglobulin heavy\/light chain assays","volume":"61","author":"Katzmann","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2019.04.002_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/cas.13125","article-title":"Abnormal heavy\/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma","volume":"108","author":"Suehara","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pathol.2019.04.002_bib19","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1515\/cclm-2015-0692","article-title":"Quantification of \u03b2 region IgA paraproteins \u2013 should we include immunochemical \u201cheavy\/light chain\u201d measurements? Counterpoint","volume":"54","author":"Paolini","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pathol.2019.04.002_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0004563214564225","article-title":"Comparison of HevyliteTM IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia","volume":"52","author":"Paolini","year":"2015","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.pathol.2019.04.002_bib21","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.7754\/Clin.Lab.2013.131010","article-title":"Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin\u202fkappa\/lambda ratios in monoclonal gammopathies","volume":"60","author":"Eckold","year":"2014","journal-title":"Clin Lab"},{"key":"10.1016\/j.pathol.2019.04.002_bib22","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood.V122.21.752.752","article-title":"Serum free light chain escape in progression and treatment resistance in multiple myeloma: a marker for the impact of intra-clonal heterogeneity","volume":"122","author":"Brioli","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.04.002_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3324\/haematol.2010.030882","article-title":"Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents","volume":"96","author":"de Larrea","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.04.002_bib24","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1073\/pnas.76.6.2937","article-title":"Clonal evolution of myeloma cells leads to quantitative changes in immunoglobulin secretion and surface antigen expression","volume":"76","author":"Leibson","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2019.04.002_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/leu.2012.197","article-title":"Immunoglobulin heavy\/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients","volume":"27","author":"Ludwig","year":"2013","journal-title":"Leukemia"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302518303933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302518303933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:25:13Z","timestamp":1758471913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302518303933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0031302518303933"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.04.002","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heavy\/light chain assay in the monitoring of multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}